Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €3.83 EUR
Change Today -0.019 / -0.49%
Volume 666.6K
As of 3:35 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter Machin Ph.D., FRSC, FMedSci

Former Member of Scientific Advisory Board, Evotec AG
AgeTotal Calculated CompensationThis person is connected to 25 board members in 1 different organizations across 2 different industries.

See Board Relationships
65--

Background*

Dr. Peter Machin, Ph.D., FRSC, FMedSci works as an Independent Drug Discovery Consultant with a medicinal chemistry background. Dr. Machin has more than thirty years experience of drug discovery and development in major pharmaceutical companies. He has held a number of senior positions; at Roche as Head of Chemistry in the UK, then at SmithKline Beecham as Vice President of Discovery Chemistry Europe and most recently, as Global Senior Vice President of Discovery Research ...

Read Full Background

Corporate Headquarters*

Manfred Eigen Campus
Hamburg, Hamburg 22419

Germany

Phone: 49 4056 0810
Fax: 49 405 608 1222

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Imperial College
Bachelor's Degree
Imperial College
PhD
Imperial College Business School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVT:GR €3.83 EUR -0.019

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Amr Mamdouh Abdel Majid Chairman of the Board and Managing Director
GlaxoSmithKline S.A.E
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOTEC AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.